<DOC>
	<DOCNO>NCT01981252</DOCNO>
	<brief_summary>This prospective , multi-center , single-blinded , non-randomized clinical trial . Enrolled subject receive two Ulthera® treatment peri-orbital peri-oral region , treatment provide 30 day apart . Follow-up visit occur 90 180 day follow treatment . Study image obtain pre-treatment , immediately post-treatment , follow-up visit .</brief_summary>
	<brief_title>Peri-orbital Peri-oral Wrinkle Reduction Trial</brief_title>
	<detailed_description />
	<criteria>Male female , age 30 75 year . Subject good health . BMI &lt; 25 Fitzpatrick wrinkle score 37 periorbital perioral area . Moderate skin laxity periorbital area contribute rhytids assess investigator . Understands accepts obligation undergo procedure , include neurotoxin filler treatment , face followup period . Willingness refrain use aspirin , Ibuprofen , Naproxen NSAID , Vitamin E 2 week prior study treatment . Willingness ability continue current daily skin care routine , exception use product contain glycolic acid , duration study . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Subjects childbearing potential must negative urine pregnancy test result must lactate Screening Visit willing able use acceptable method birth control study . Absence physical psychological condition unacceptable investigator . Willingness ability provide write consent studyrequired photography adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent HIPAA authorization prior performance studyrelated procedure . Presence active systemic local skin disease may affect wound healing . BMI equal great 25 Severe solar elastosis . Excessive subcutaneous fat area ( ) treat . Mild severe skin laxity area ( ) treat . Significant scarring area ( ) treat . Open wound lesion area ( ) treat . Severe cystic acne area ( ) treat . Active implantables ( e.g. , pacemaker defibrillator ) metallic implant treatment area . Inability understand protocol give inform consent . Microdermabrasion , prescription level glycolic acid treatment treatment area ( ) within 4 week prior study participation study . Marked asymmetry , ptosis , excessive dermatochalasis , deep dermal scarring , thick sebaceous skin area ( ) treat . History chronic drug alcohol abuse . History autoimmune disease . History Bell 's Palsy epilepsy . History diabetes . Has know allergy , know history sensitivity , lidocaine , tetracaine , paraaminobenzoic acid ( PABA ) . Concomitant therapy , investigator 's opinion , would interfere evaluation safety efficacy study device . Subjects anticipate need surgery overnight hospitalization study . Subjects , investigator 's opinion , history poor cooperation , noncompliance medical treatment , unreliability . Concurrent enrollment study involve use investigational device drug . Current smoker history smoking last five year . History follow cosmetic treatment area ( ) treat : 1 . Skin tighten procedure within past year ; 2 . Injectable filler type within past 12 24 month , depend type ; 3 . Neurotoxins within past six month ; 4 . Ablative resurface laser treatment ; 5 . Nonablative , rejuvenative laser light treatment within past six month ; 6 . Surgical dermabrasion deep facial peel ; 7 . Facelift , blepharoplasty , browlift within past 2 year ; 8 . Any history contour thread . History use follow prescription medication : 1 . Accutane systemic retinoids within past six month ; 2 . Topical Retinoids within past four week ; 3 . Antiplatelet agents/Anticoagulants ; 4 . Psychiatric drug investigator opinion would impair subject understand protocol requirement understand signing informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ Treatment</keyword>
	<keyword>Ulthera , Inc .</keyword>
	<keyword>Micro-focused Ultrasound Visualization ( MFU-V )</keyword>
</DOC>